We understand the unique compliance challenges of your sector — because we've worked in them for over two decades. Here's how we help.
Pharmaceutical development sits at the intersection of biological resource access, biosafety regulation, and advanced regulatory strategy. Whether you're developing a drug from natural products, engineering a gene therapy, or working with cell lines, your project must navigate multiple regulatory regimes simultaneously.
We conduct compliance audits, develop regulatory strategies, and maintain relationships with EMA and global competent authorities to de-risk your approval pathway.
Genetic improvement programs for livestock and companion animals require careful navigation of biosafety frameworks and regulatory compliance. Genetically modified animals face distinct regulatory scrutiny across jurisdictions, and breeding facilities must meet specific safety standards.
We help you navigate genetic improvement strategies, biosafety protocols for breeding facilities, and regulatory compliance for genetically modified animals across different markets.
New Genomic Techniques like CRISPR are accelerating crop improvement, but the regulatory landscape is complex and fragmented. What's approved in the USA faces different scrutiny in the EU. Successfully commercializing plant biotech requires strategic navigation of biotechnological frameworks.
We guide you through field trials, ITPGRFA compliance, GM crop regulations, NGT frameworks, and stewardship programs that build trust with regulators and stakeholders.
Environmental biotechnology addresses some of the world's most pressing sustainability challenges — from bioremediation of contaminated sites to biofuels and circular economy applications. These solutions require robust biosafety and genetic resource management frameworks to ensure environmental safety and compliance.
We provide regulatory guidance on bioremediation projects, biofuel development, environmental biotechnology applications, and sustainability-focused biotech initiatives.
Industrial biotechnology harnesses biological processes to produce enzymes, chemicals, and materials at commercial scale. Production facilities must meet rigorous biosafety standards, and sourcing of biological inputs requires strict ABS compliance and genetic resource due diligence across global supply chains.
We help you navigate industrial-scale biosafety, genetic resource compliance, fermentation protocols, and supply chain due diligence for bio-based chemical and enzyme production.
The cosmetics industry increasingly relies on natural ingredients sourced from biological resources across the globe. Sourcing these ingredients requires careful Access and Benefit Sharing compliance under the Nagoya Protocol and national ABS laws to ensure sustainable supply chains and ethical resource access.
We provide ABS compliance support for cosmetic ingredient sourcing, Nagoya Protocol implementation, supply chain due diligence, and documentation for natural product cosmetics.
Fragrance ingredients derived from biological resources — essential oils, plant extracts, and natural compounds — require rigorous ABS compliance and supply chain due diligence. The fragrance industry's reliance on genetic resources from biodiverse regions makes Nagoya Protocol compliance and benefit-sharing frameworks essential.
We help fragrance companies navigate natural ingredient sourcing, ABS compliance, Nagoya Protocol implementation, and transparent supply chain documentation.
The food industry increasingly leverages biotechnology for novel ingredients, food-grade microbial strains, and innovative production methods. Novel food authorization requires navigating complex regulatory frameworks while ensuring proper genetic resource compliance and biosafety protocols for food-grade biotechnology applications.
We guide you through novel food authorization pathways, food-grade biotechnology regulations, genetic resource compliance for food ingredients, and market entry strategies across jurisdictions.